Skip to main content
PMC home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1993 Nov;39:2385–2390.

Screening for prostate cancer. How can patients give informed consent?

K G Marshall 1
PMCID: PMC2379946  PMID: 7505673

Abstract

Many urologists in North America are increasingly enthusiastic about prostatic cancer screening. Annual digital rectal examination is almost universally endorsed, and prostate-specific antigen testing is favored by most. But doctors really should not screen by either method without patients' informed consent. However, the information required for informed consent is complex and contradictory, difficult for physicians to give and for patients to absorb.

Full text

PDF
2387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boring C. C., Squires T. S., Tong T. Cancer statistics, 1991. CA Cancer J Clin. 1991 Jan-Feb;41(1):19–36. doi: 10.3322/canjclin.41.1.19. [DOI] [PubMed] [Google Scholar]
  2. Catalona W. J. Patient selection for, results of, and impact on tumor resection of potency-sparing radical prostatectomy. Urol Clin North Am. 1990 Nov;17(4):819–826. [PubMed] [Google Scholar]
  3. Chodak G. W., Keller P., Schoenberg H. Routine screening for prostate cancer using the digital rectal examination. Prog Clin Biol Res. 1988;269:87–98. [PubMed] [Google Scholar]
  4. Chodak G. W., Schoenberg H. W. Progress and problems in screening for carcinoma of the prostate. World J Surg. 1989 Jan-Feb;13(1):60–64. doi: 10.1007/BF01671155. [DOI] [PubMed] [Google Scholar]
  5. Chodak G. W. Screening for prostate cancer. Role of ultrasonography. Urol Clin North Am. 1989 Nov;16(4):657–661. [PubMed] [Google Scholar]
  6. Dixon T. In pursuit of the prostate. Can Fam Physician. 1992 Oct;38:2285–2292. [PMC free article] [PubMed] [Google Scholar]
  7. Drago J. R., Badalament R. A., Nesbitt J. A. Radical prostatectomy 1972-1987 single institutional experience: comparison of standard radical prostatectomy and nerve-sparing technique. Urology. 1990 May;35(5):377–380. doi: 10.1016/0090-4295(90)80075-x. [DOI] [PubMed] [Google Scholar]
  8. Dähnert W. F., Hamper U. M., Eggleston J. C., Walsh P. C., Sanders R. C. Prostatic evaluation by transrectal sonography with histopathologic correlation: the echopenic appearance of early carcinoma. Radiology. 1986 Jan;158(1):97–102. doi: 10.1148/radiology.158.1.3510032. [DOI] [PubMed] [Google Scholar]
  9. George N. J. Natural history of localised prostatic cancer managed by conservative therapy alone. Lancet. 1988 Mar 5;1(8584):494–497. doi: 10.1016/s0140-6736(88)91294-9. [DOI] [PubMed] [Google Scholar]
  10. Gerber G. S., Chodak G. W. Digital rectal examination in the early detection of prostate cancer. Urol Clin North Am. 1990 Nov;17(4):739–744. [PubMed] [Google Scholar]
  11. Gibbons R. P., Correa R. J., Jr, Brannen G. E., Weissman R. M. Total prostatectomy for clinically localized prostatic cancer: long-term results. J Urol. 1989 Mar;141(3):564–566. doi: 10.1016/s0022-5347(17)40895-0. [DOI] [PubMed] [Google Scholar]
  12. Guinan P., Bhatti R., Ray P. An evaluation of prostate specific antigen in prostatic cancer. J Urol. 1987 Apr;137(4):686–689. doi: 10.1016/s0022-5347(17)44175-9. [DOI] [PubMed] [Google Scholar]
  13. Handley R., Carr T. W., Travis D., Powell P. H., Hall R. R. Deferred treatment for prostate cancer. Br J Urol. 1988 Sep;62(3):249–253. doi: 10.1111/j.1464-410x.1988.tb04328.x. [DOI] [PubMed] [Google Scholar]
  14. Hudson M. A., Bahnson R. R., Catalona W. J. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol. 1989 Oct;142(4):1011–1017. doi: 10.1016/s0022-5347(17)38972-3. [DOI] [PubMed] [Google Scholar]
  15. Johansson J. E., Adami H. O., Andersson S. O., Bergström R., Krusemo U. B., Kraaz W. Natural history of localised prostatic cancer. A population-based study in 223 untreated patients. Lancet. 1989 Apr 15;1(8642):799–803. doi: 10.1016/s0140-6736(89)92269-1. [DOI] [PubMed] [Google Scholar]
  16. Middleton R. G., Larsen R. H. Selection of patients with stage B prostate cancer for radical prostatectomy. Urol Clin North Am. 1990 Nov;17(4):779–785. [PubMed] [Google Scholar]
  17. Mold J. W., Holtgrave D. R., Bisonni R. S., Marley D. S., Wright R. A., Spann S. J. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis. J Fam Pract. 1992 May;34(5):561–568. [PubMed] [Google Scholar]
  18. Mueller E. J., Crain T. W., Thompson I. M., Rodriguez F. R. An evaluation of serial digital rectal examinations in screening for prostate cancer. J Urol. 1988 Dec;140(6):1445–1447. doi: 10.1016/s0022-5347(17)42069-6. [DOI] [PubMed] [Google Scholar]
  19. Muldoon L., Resnick M. I. Results of ultrasonography of the prostate. Urol Clin North Am. 1989 Nov;16(4):693–702. [PubMed] [Google Scholar]
  20. Pedersen K. V., Carlsson P., Varenhorst E., Löfman O., Berglund K. Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. BMJ. 1990 Apr 21;300(6731):1041–1044. doi: 10.1136/bmj.300.6731.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rannikko S., Salo J. O. Radical prostatectomy as treatment of localized prostatic cancer. Early results, with special focus on transrectal ultrasound for local staging. Scand J Urol Nephrol. 1990;24(2):103–107. doi: 10.3109/00365599009180372. [DOI] [PubMed] [Google Scholar]
  22. Rock R. C., Chan D. W., Bruzek D., Waldron C., Oesterling J., Walsh P. Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen. Clin Chem. 1987 Dec;33(12):2257–2261. [PubMed] [Google Scholar]
  23. Scardino P. T. Early detection of prostate cancer. Urol Clin North Am. 1989 Nov;16(4):635–655. [PubMed] [Google Scholar]
  24. Scardino P. T., Weaver R., Hudson M. A. Early detection of prostate cancer. Hum Pathol. 1992 Mar;23(3):211–222. doi: 10.1016/0046-8177(92)90102-9. [DOI] [PubMed] [Google Scholar]
  25. Schröder F. H. Prostate cancer: to screen or not to screen? BMJ. 1993 Feb 13;306(6875):407–408. doi: 10.1136/bmj.306.6875.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Shinohara K., Scardino P. T., Carter S. S., Wheeler T. M. Pathologic basis of the sonographic appearance of the normal and malignant prostate. Urol Clin North Am. 1989 Nov;16(4):675–691. [PubMed] [Google Scholar]
  27. Smith P. H. The case for no initial treatment of localized prostate cancer. Urol Clin North Am. 1990 Nov;17(4):827–834. [PubMed] [Google Scholar]
  28. Spurgeon D. Canadian MDs begin major push to promote early detection of prostate cancer. CMAJ. 1992 Jul 15;147(2):220–222. [PMC free article] [PubMed] [Google Scholar]
  29. Thompson I. M., Fair W. R. Screening for carcinoma of the prostate: efficacy of available screening tests. World J Surg. 1989 Jan-Feb;13(1):65–70. doi: 10.1007/BF01671156. [DOI] [PubMed] [Google Scholar]
  30. Thompson I. M., Rounder J. B., Teague J. L., Peek M., Spence C. R. Impact of routine screening for adenocarcinoma of the prostate on stage distribution. J Urol. 1987 Mar;137(3):424–426. doi: 10.1016/s0022-5347(17)44055-9. [DOI] [PubMed] [Google Scholar]
  31. Thompson I. M., Zeidman E. J. Current urological practice: routine urological examination and early detection of carcinoma of the prostate. J Urol. 1992 Aug;148(2 Pt 1):326–330. doi: 10.1016/s0022-5347(17)36585-0. [DOI] [PubMed] [Google Scholar]
  32. Waterhouse R. L., Resnick M. I. The use of transrectal prostatic ultrasonography in the evaluation of patients with prostatic carcinoma. J Urol. 1989 Feb;141(2):233–239. doi: 10.1016/s0022-5347(17)40729-4. [DOI] [PubMed] [Google Scholar]
  33. Whitmore W. F., Jr Natural history and staging of prostate cancer. Urol Clin North Am. 1984 May;11(2):205–220. [PubMed] [Google Scholar]
  34. Whitmore W. F., Jr Natural history of low-stage prostatic cancer and the impact of early detection. Urol Clin North Am. 1990 Nov;17(4):689–697. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES